Liver cancer trial aims to stop return of disease with Pre-Surgery combo
Disease control
Not yet recruiting
This study tests whether giving a combination of an immunotherapy drug (sintilimab) and targeted radiation before surgery can lower the chance of liver cancer coming back. About 110 adults with resectable liver cancer will be randomly assigned to receive the combination before su…
Phase: PHASE2 • Sponsor: Lei ZHAO • Aim: Disease control
Last updated May 08, 2026 12:02 UTC